Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Treg Cells for AGVHD in Non-myeloablative UCB Transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Investigator Initiated Phase 1 Study of TBI-1201
- Status
- COMPLETED
- Phase
- PHASE1
Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Hematopoietic Stem Cell Transplant for Sickle Cell Disease
- Status
- COMPLETED
- Phase
- PHASE1
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Reduced Intensity Conditioning (RIC) Regimen and Post-transplant Cyclophosphamide in Haploidentical Bone Marrow Transplantation in in Patients With Poor Prognosis Lymphomas
- Status
- UNKNOWN
- Phase
- PHASE2
BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance
- Status
- TERMINATED
- Phase
- PHASE2
AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE4
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia
- Status
- COMPLETED
- Phase
- NA
TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment
- Status
- TERMINATED
- Phase
- PHASE2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2